Amenorrhea natural history, complications and prognosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 9: Line 9:
==Natural History, Complications, and Prognosis==
==Natural History, Complications, and Prognosis==
===Natural History===
===Natural History===
*The symptoms of [[puberty]] usually develop in the second decade of life, 12-13 years of age and usually before 15 years of age. The main symptom of [[puberty]] in female gender is [[menarche]].<ref name="ChiavaroliDAdamo2011">{{cite journal|last1=Chiavaroli|first1=Valentina|last2=DAdamo|first2=Ebe|last3=Diesse|first3=Laura|last4=de|first4=Tommaso|last5=Chiarelli|first5=Francesco|last6=Moh|first6=Angelika|title=Primary and Secondary Amenorrhea|year=2011|doi=10.5772/17675}}</ref>
*If left untreated, all patients of amenorrhea may progress to develop [[infertility]] and [[osteoporosis]].  
*In primary amenorrhea:
**Absence of [[menarche]] until 15 years of age, in the presence of other [[secondary sexual characteristics]].
**Absence of [[menarche]] after 5 years of [[thelarche]], if [[thelarche]] occurred before 10 years of age.<ref name="Herman-GiddensSlora1997">{{cite journal|last1=Herman-Giddens|first1=M. E.|last2=Slora|first2=E. J.|last3=Wasserman|first3=R. C.|last4=Bourdony|first4=C. J.|last5=Bhapkar|first5=M. V.|last6=Koch|first6=G. G.|last7=Hasemeier|first7=C. M.|title=Secondary Sexual Characteristics and Menses in Young Girls Seen in Office Practice: A Study from the Pediatric Research in Office Settings Network|journal=PEDIATRICS|volume=99|issue=4|year=1997|pages=505–512|issn=0031-4005|doi=10.1542/peds.99.4.505}}</ref>
*In secondary amenorrhea:
**[[Menstrual cycle]] is interrupted for at least 3 months, however [[Menstrual cycle|menstrual cycles]] were regular before.<ref name="ChiavaroliDAdamo2011" />
**[[Menstrual cycle]] is interrupted for at least 6 months, however [[Menstrual cycle|menstrual cycles]] were irregular before.<ref>{{cite book | last = Fritz | first = Marc | title = Clinical gynecologic endocrinology and infertility | publisher = Wolters Kluwer Health/Lippincott Williams & Wilkins | location = Philadelphia | year = 2011 | isbn = 978-0781779685 }}</ref>
*If left untreated, all patients with amenorrhea may progress to develop [[infertility]] and [[osteoporosis]].  
*The majority of amenorrhea cases are caused by four conditions, which include [[polycystic ovary syndrome]], [[hypothalamic]] amenorrhea, [[hyperprolactinemia]], and [[ovarian failure]].
*The majority of amenorrhea cases are caused by four conditions, which include [[polycystic ovary syndrome]], [[hypothalamic]] amenorrhea, [[hyperprolactinemia]], and [[ovarian failure]].
*In case of amenorrhea secondary to [[Asherman syndrome|Asherman's syndrome]], patients usually have a past medical history of [[uterine]] surgery and [[scarring]].
*[[Polycystic ovary syndrome|Polycystic ovary syndrome (PCOS)]], if left untreated can lead to [[heart disease]] from elevated [[cholesterol]] and increased levels of [[androgens]]. Long periods of not having [[menstrual cycles]] leads to unopposed exposure of [[endometrium]] to [[estrogen]], can result in [[endometrial cancer]].<ref name="pmid26261426">{{cite journal |vauthors=Palomba S, Santagni S, Falbo A, La Sala GB |title=Complications and challenges associated with polycystic ovary syndrome: current perspectives |journal=Int J Womens Health |volume=7 |issue= |pages=745–63 |year=2015 |pmid=26261426 |pmc=4527566 |doi=10.2147/IJWH.S70314 |url=}}</ref>
*[[Polycystic ovary syndrome|Polycystic ovary syndrome (PCOS)]], if left untreated can lead to [[heart disease]] from elevated [[cholesterol]] and increased levels of [[androgens]]. Long periods of not having [[menstrual cycles]] leads to unopposed exposure of [[endometrium]] to [[estrogen]], can result in [[endometrial cancer]].<ref name="pmid26261426">{{cite journal |vauthors=Palomba S, Santagni S, Falbo A, La Sala GB |title=Complications and challenges associated with polycystic ovary syndrome: current perspectives |journal=Int J Womens Health |volume=7 |issue= |pages=745–63 |year=2015 |pmid=26261426 |pmc=4527566 |doi=10.2147/IJWH.S70314 |url=}}</ref>
*In functional ([[hypothalamic]]) amenorrhea, the patient usually reports normal regular [[Menstrual cycles|cycles]] in the past, with sudden interruption of menstrual cycles for more than 3 months. There is almost always a history of [[weight loss]] (severe), excessive [[exercise]], or drastic [[emotional stress]] prior to cessation of [[menstruation]].<ref name="pmid25201001">Meczekalski B, Katulski K, Czyzyk A, Podfigurna-Stopa A, Maciejewska-Jeske M (2014) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=25201001 Functional hypothalamic amenorrhea and its influence on women's health.] ''J Endocrinol Invest'' 37 (11):1049-56. [http://dx.doi.org/10.1007/s40618-014-0169-3 DOI:10.1007/s40618-014-0169-3] PMID: [https://pubmed.gov/25201001 25201001]</ref>
*In functional ([[hypothalamic]]) amenorrhea, the patient usually reports normal regular [[Menstrual cycles|cycles]] in the past, with sudden interruption of menstrual cycles for more than 3 months. There is almost always a history of [[weight loss]] (severe), excessive [[exercise]], or drastic [[emotional stress]] prior to cessation of [[menstruation]].<ref name="pmid25201001">Meczekalski B, Katulski K, Czyzyk A, Podfigurna-Stopa A, Maciejewska-Jeske M (2014) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=25201001 Functional hypothalamic amenorrhea and its influence on women's health.] ''J Endocrinol Invest'' 37 (11):1049-56. [http://dx.doi.org/10.1007/s40618-014-0169-3 DOI:10.1007/s40618-014-0169-3] PMID: [https://pubmed.gov/25201001 25201001]</ref>
Line 24: Line 16:
*Amenorrhea from [[hyperprolactinemia]] can be caused by [[prolactin]] overproduction or [[dopamine]] suppression, and is mostly seen in middle aged women. Idiopathic [[hyperprolactinemia]] is elevated serum [[prolactin]] level without any [[brain]] lesion or other pathologies.<ref name="pmid2058949">{{cite journal |vauthors=Mattei AM, Severini V, Crosignani PG |title=Natural history of hyperprolactinemia |journal=Ann. N. Y. Acad. Sci. |volume=626 |issue= |pages=130–6 |year=1991 |pmid=2058949 |doi= |url=}}</ref>
*Amenorrhea from [[hyperprolactinemia]] can be caused by [[prolactin]] overproduction or [[dopamine]] suppression, and is mostly seen in middle aged women. Idiopathic [[hyperprolactinemia]] is elevated serum [[prolactin]] level without any [[brain]] lesion or other pathologies.<ref name="pmid2058949">{{cite journal |vauthors=Mattei AM, Severini V, Crosignani PG |title=Natural history of hyperprolactinemia |journal=Ann. N. Y. Acad. Sci. |volume=626 |issue= |pages=130–6 |year=1991 |pmid=2058949 |doi= |url=}}</ref>
===Complications===
===Complications===
*Common complications of amenorrhea are based on the underlying disorder inducing amenorrhea.
*Common complications of amenorrhea are based on the underlying disorder inducing amenorrhea. The majority of amenorrhea cases are caused by four conditions, which include [[polycystic ovary syndrome]], [[hypothalamic]] amenorrhea, [[hyperprolactinemia]], and [[ovarian failure]].
*Common complications of amenorrhea from [[PCOS]] include:
*Common complications of amenorrhea from [[PCOS]] include:
**[[Endometrial hyperplasia]]/[[Endometrial cancer]]
**[[Endometrial hyperplasia]]/[[Endometrial cancer]]
Line 34: Line 26:
**[[Miscarriage]]
**[[Miscarriage]]
**[[Infertility]]
**[[Infertility]]
*[[Hyperprolactinemia]] leads to [[galactorrhea]], decreasing [[libido]], and [[pregnancy]] complications. In case of [[prolactin]]-producing [[pituitary adenoma]], massive enlargement of the [[tumor]] may influence [[Vision loss|vision]] and [[pituitary]] function. It can also cause [[osteopenia]] and [[osteoporosis]] in pre-[[menopausal]] women.<ref name="pmid10649820">{{cite journal |vauthors=Sanfilippo JS |title=Implications of not treating hyperprolactinemia |journal=J Reprod Med |volume=44 |issue=12 Suppl |pages=1111–5 |year=1999 |pmid=10649820 |doi= |url=}}</ref>
*[[Hyperprolactinemia]] leads to [[galactorrhea]], decreased [[libido]], and pregnancy complications. In case of [[prolactin]]-producing [[pituitary adenoma]], massive enlargement of the [[tumor]] may affect [[Vision loss|vision]] and [[pituitary]] function. It can also cause [[osteopenia]] and [[osteoporosis]] in pre-[[menopausal]] women.<ref name="pmid10649820">{{cite journal |vauthors=Sanfilippo JS |title=Implications of not treating hyperprolactinemia |journal=J Reprod Med |volume=44 |issue=12 Suppl |pages=1111–5 |year=1999 |pmid=10649820 |doi= |url=}}</ref>
*Common complications of [[premature ovarian failure]] are [[infertility]], [[osteoporosis]], [[depression]]/[[anxiety]], [[cardiac disease]], and [[dementia]].<ref name="urlPremature ovarian failure - Symptoms and causes - Mayo Clinic">{{cite web |url=http://www.mayoclinic.org/diseases-conditions/premature-ovarian-failure/symptoms-causes/dxc-20255567 |title=Premature ovarian failure - Symptoms and causes - Mayo Clinic |format= |work= |accessdate=}}</ref>
*Common complications of [[premature ovarian failure]] are [[infertility]], [[osteoporosis]], [[depression]]/[[anxiety]], [[cardiac disease]], and [[dementia]].<ref name="urlPremature ovarian failure - Symptoms and causes - Mayo Clinic">{{cite web |url=http://www.mayoclinic.org/diseases-conditions/premature-ovarian-failure/symptoms-causes/dxc-20255567 |title=Premature ovarian failure - Symptoms and causes - Mayo Clinic |format= |work= |accessdate=}}</ref>
*Patients with [[hypothalamic]] (functional) amenorrhea experience various complications, such as [[infertility]], decrease in [[Bone mineral density|bone mineral density (BMD)]], increased risk for [[fracture]] along with [[cardiovascular]] and [[psychological]] problems.<ref name="pmid25201001" />
*Patients with [[hypothalamic]] (functional) amenorrhea experience various complications, such as [[infertility]], decrease in [[Bone mineral density|bone mineral density (BMD)]], increased risk for [[fracture]], along with [[cardiovascular]] and [[psychological]] problems.<ref name="pmid25201001" />
*The most important complication of [[premature ovarian failure]] is [[infertility]], that is preventable to some extent with appropriate therapies. [[Bone loss]] and [[Mental disorder|mental problems]] are other complications.<ref name="pmid19196677">{{cite journal| author=Nelson LM| title=Clinical practice. Primary ovarian insufficiency. | journal=N Engl J Med | year= 2009 | volume= 360 | issue= 6 | pages= 606-14 | pmid=19196677 | doi=10.1056/NEJMcp0808697 | pmc=2762081 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19196677  }}</ref>
*The most important complication of [[premature ovarian failure]] is [[infertility]], that is preventable to some extent with appropriate therapies. [[Bone loss]] and [[Mental disorder|mental problems]] are other complications.<ref name="pmid19196677">{{cite journal| author=Nelson LM| title=Clinical practice. Primary ovarian insufficiency. | journal=N Engl J Med | year= 2009 | volume= 360 | issue= 6 | pages= 606-14 | pmid=19196677 | doi=10.1056/NEJMcp0808697 | pmc=2762081 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19196677  }}</ref>
===Prognosis===
===Prognosis===

Revision as of 20:46, 19 October 2017

Amenorrhea Microchapters

Home

Patient Information

Primary amenorrhea
Secondary amenorrhea

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Amenorrhea from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Amenorrhea natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Amenorrhea natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Amenorrhea natural history, complications and prognosis

CDC on Amenorrhea natural history, complications and prognosis

Amenorrhea natural history, complications and prognosis in the news

Blogs on Amenorrhea natural history, complications and prognosis

Directions to Hospitals Treating Amenorrhea

Risk calculators and risk factors for Amenorrhea natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Eiman Ghaffarpasand, M.D. [2]

Overview

If left untreated, patients with amenorrhea may progress to develop infertility and osteoporosis. Common complications of amenorrhea are based on underlying disorder that induce amenorrhea. Prognosis is generally excellent and the mortality rate of patients with amenorrhea is approximately less than 1%, generally in brain lesions.

Natural History, Complications, and Prognosis

Natural History

Complications

Prognosis

References

  1. Palomba S, Santagni S, Falbo A, La Sala GB (2015). "Complications and challenges associated with polycystic ovary syndrome: current perspectives". Int J Womens Health. 7: 745–63. doi:10.2147/IJWH.S70314. PMC 4527566. PMID 26261426.
  2. 2.0 2.1 Meczekalski B, Katulski K, Czyzyk A, Podfigurna-Stopa A, Maciejewska-Jeske M (2014) Functional hypothalamic amenorrhea and its influence on women's health. J Endocrinol Invest 37 (11):1049-56. DOI:10.1007/s40618-014-0169-3 PMID: 25201001
  3. Vegetti W, Marozzi A, Manfredini E, Testa G, Alagna F, Nicolosi A, Caliari I, Taborelli M, Tibiletti MG, Dalprà L, Crosignani PG (2000). "Premature ovarian failure". Mol. Cell. Endocrinol. 161 (1–2): 53–7. PMID 10773392.
  4. Mattei AM, Severini V, Crosignani PG (1991). "Natural history of hyperprolactinemia". Ann. N. Y. Acad. Sci. 626: 130–6. PMID 2058949.
  5. Sanfilippo JS (1999). "Implications of not treating hyperprolactinemia". J Reprod Med. 44 (12 Suppl): 1111–5. PMID 10649820.
  6. "Premature ovarian failure - Symptoms and causes - Mayo Clinic".
  7. Nelson LM (2009). "Clinical practice. Primary ovarian insufficiency". N Engl J Med. 360 (6): 606–14. doi:10.1056/NEJMcp0808697. PMC 2762081. PMID 19196677.
  8. Hart R (2007). "Polycystic ovarian syndrome--prognosis and treatment outcomes". Curr. Opin. Obstet. Gynecol. 19 (6): 529–35. doi:10.1097/GCO.0b013e3282f10e22. PMID 18007129.
  9. "Hyperprolactinemia Follow-up: Further Outpatient Care, Complications, Prognosis".

Template:WH Template:WS